NEW YORK (GenomeWeb News) – CompanionDx and GenomOncology will develop a series of next-generation sequencing-based assays for cancer, the companies said today.

CompanionDx will use GenomOncology's GO Clinical Workbench software to develop a clinical report from the raw sequencing data.

The GO Clinical Workbench analysis is fully traceable and includes a decision support tool for the interpretation of somatic mutations.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In a series of articles, medical journals debate the necessity of conflict-of-interest policies.

Irwin Rose, who won the 2004 Nobel Prize in Chemistry for his work on ubiquitin-mediated protein degradation, has died.

In Cell this week: biobank of colorectal cancer organoids, ancient wolf genome analysis, and more.

With cloud computing becoming more attractive to researchers, Nature News offers some tips on how to get going.

Jul
14
Sponsored by
Agilent Technologies

This online seminar will outline a recent example of the use of molecular barcoding in combination with next-generation sequencing to detect somatic mosaicism in cancer patients.